Cansortium Inc. (OTCMKTS:CNTMF) Short Interest Up 370.1% in May

Cansortium Inc. (OTCMKTS:CNTMF) was the target of a significant growth in short interest in May. As of May 29th, there was short interest totaling 208,442 shares, a growth of 370.1% from the May 14th total of 44,344 shares. Based on an average daily volume of 516,366 shares, the short-interest ratio is currently 0.4 days.

Cansortium Trading Down 6.4%

CNTMF stock traded down $0.00 on Friday, hitting $0.02. The company had a trading volume of 723,845 shares, compared to its average volume of 450,404. Cansortium has a 12-month low of $0.02 and a 12-month high of $0.09. The stock’s 50-day simple moving average is $0.03 and its 200 day simple moving average is $0.04.

Cansortium (OTCMKTS:CNTMF) last issued its quarterly earnings results on Thursday, April 30th. The company reported ($0.16) earnings per share for the quarter. During the same period last year, the firm posted ($0.14) EPS.

Cansortium Company Profile

Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.